Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer

NCT03618706 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03618706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03618706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Unknown status
Start date
May 10, 2018
Completion date
May 9, 2023
Enrollment
107 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent ovarian cancer